Atomic’s EmployerLink supports worker’s compensation insurance, earned wage access, and financial wellness benefits with additional…
VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE:…
SAN FRANCISCO, Nov. 16, 2022 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Software Effective Solutions’ Medcana Subsidiaries Launch Construction Proceedings Software Effective Solutions’ Medcana Subsidiaries Launch Construction…
LEXINGTON, Mass., Nov. 16, 2022 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with…
SANTA CLARA, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…
701% revenue growth underscores BrightInsight’s position as the de facto digital health platform for the…
TUSTIN, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract…
MONTREAL, Nov. 16, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company…
Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data…
CHESTERBROOK, Pa., Nov. 16, 2022 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN) (“Trevena” or the…
REHOVOT, Israel and WILMINGTON, Del., Nov. 16, 2022 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq:…
AGOURA HILLS, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
Pharmaceutical Grade Psilocybin Synthesized By Mindset’s Patent Pending Process TORONTO, Nov. 16, 2022 (GLOBE NEWSWIRE)…
Affy Services, Smart Automated Retail Network Parent Company, to Also Represent Todos for Traditional Shelf…
PharmAla will be the exclusive global reseller of Mindset’s cGMP psilocybin to appropriately licensed clinical…
BASEL, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a…
Existing senior bonds upsized by $70 million with additional investment from a consortium of institutional…
Existing senior bonds upsized by $70 million with additional investment from a consortium of institutional…
LONDON and PHOENIX, Nov. 16, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT), a…